NPI: 1881648061 · FEDERAL WAY, WA 98003 · Skilled Nursing Facility · NPI assigned 05/20/2006
Authorized official CROSS, CINDY controls 20+ related entities in our dataset. Read more
| Authorized Official | CROSS, CINDY (ASSISTANT SECRETARY) |
| NPI Enumeration Date | 05/20/2006 |
Other providers sharing the same authorized official: CROSS, CINDY
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 492 | $785.73 |
| 2019 | 867 | $7K |
| 2020 | 2,392 | $66K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | 1,560 | 213 | $12K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 1,010 | 141 | $12K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 102 | 99 | $11K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 13 | 13 | $7K |
| 96361 | Intravenous infusion, hydration; each additional hour | 20 | 19 | $6K |
| 99285 | Emergency department visit for the evaluation and management, high severity with immediate threat to life | 37 | 37 | $6K |
| 99283 | Emergency department visit for the evaluation and management, moderate severity | 40 | 40 | $5K |
| 99284 | Emergency department visit for the evaluation and management, high severity | 38 | 38 | $5K |
| 80053 | Comprehensive metabolic panel | 108 | 105 | $2K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 16 | 16 | $2K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 124 | 124 | $925.72 |
| 97535 | Self-care/home management training, each 15 minutes | 156 | 33 | $736.56 |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 23 | 23 | $722.69 |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 32 | 31 | $576.64 |
| 36415 | Collection of venous blood by venipuncture | 90 | 84 | $496.92 |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 16 | 16 | $439.05 |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 19 | 18 | $382.44 |
| 71045 | Radiologic examination, chest; single view | 17 | 17 | $373.72 |
| 84484 | 18 | 16 | $345.57 | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 20 | 20 | $262.87 |
| 80048 | Basic metabolic panel (calcium, ionized) | 14 | 12 | $248.51 |
| 84443 | Thyroid stimulating hormone (TSH) | 15 | 15 | $248.51 |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 13 | 12 | $228.05 |
| 83690 | 18 | 18 | $179.43 | |
| 96375 | Therapeutic injection; each additional sequential IV push | 21 | 20 | $140.30 |
| 87086 | Culture, bacterial; quantitative colony count, urine | 14 | 14 | $93.65 |
| 83735 | 15 | 15 | $81.71 | |
| 85610 | 15 | 14 | $72.58 | |
| 81025 | 17 | 17 | $66.12 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 16 | 16 | $34.94 |
| 81001 | 30 | 29 | $31.35 | |
| 81003 | 13 | 13 | $27.24 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 23 | 21 | $0.00 |
| J2704 | Injection, propofol, 10 mg | 13 | 13 | $0.00 |
| G8982 | Changing & maintaining body position functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting | 21 | 12 | $0.00 |
| G8981 | Changing & maintaining body position functional limitation, current status, at therapy episode outset and at reporting intervals | 16 | 12 | $0.00 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 18 | 16 | $0.00 |